| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13D · 1 security · may seek to influence control | ||||||
|
Psyence Biomedical Ltd.
13D/A
PBM · 74449F308
|
4.9% |
1/13/2026
Event 1/8/2026
|
||||
| KAOS Capital Ltd. | 4.9% | |||||
| Adam Arviv | 4.9% | |||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.